UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036621
Receipt number R000041721
Scientific Title Single-arm feasibility study of laparoscopic gastrectomy for upper-third gastric cancer and esophago-gastric junction cancer
Date of disclosure of the study information 2019/10/01
Last modified on 2019/04/28 19:27:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Single-arm feasibility study of laparoscopic gastrectomy for upper-third gastric cancer and esophago-gastric junction cancer

Acronym

Single-arm feasibility study of laparoscopic gastrectomy for upper-third gastric cancer and esophago-gastric junction cancer

Scientific Title

Single-arm feasibility study of laparoscopic gastrectomy for upper-third gastric cancer and esophago-gastric junction cancer

Scientific Title:Acronym

Single-arm feasibility study of laparoscopic gastrectomy for upper-third gastric cancer and esophago-gastric junction cancer

Region

Japan


Condition

Condition

Upper-third gastric cancer and esophago-gastric junction cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to validate non-inferiority in safety of laparoscopic gastrectomy compared to open gastrectomy for cT1N2-3, cT2N0-3, cT3N0 and cT4aN0 upper-third gastric cancer or esophago-gastric junction cancer.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of anastomotic leakage

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Laparoscopic proximal gastrectomy or laparoscopic total gastrectomy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Pathologically diagnosed as gastric or esophago-gastric adenocarcinoma.
2) Curatively resectable cT1N2-3M0, cT2N0-3M0, cT3N0M0 and cT4N0M0 (excluding bulky N2) cancer by proximal or total gastrectomy without splenectomy.
3) Older than 20 y.o.
4) PS 0~2
5) No previous treatment for gastric cancer.
6) BMI<35
7) Consented to be enrolled to the trial from participant him/herself.

Key exclusion criteria

1) Double cancer
2) cT4b
3) P1, Cy1 or cM1
4) Cases of received neoadjuvant treatment.
5) Pregnant or breast feeding.
6) Mental disorder
7) Continuous systemic administration of steroid.
8) Infectious disease with systemic treatment.
9) Uncontrollable diabetes mellitus.
10) Unstable coronary angina or history of MI within 6 months.
11) Respiratory disease with continuous administration of oxygen.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Soya
Middle name
Last name Nunobe

Organization

Cancer Institute Hospital of JFCR

Division name

Gastroenterology Center

Zip code

1358550

Address

3-8-31, Ariake, Koto-ku, Tokyo, Japan

TEL

+81-3-3520-0111

Email

souya.nunobe@jfcr.or.jp


Public contact

Name of contact person

1st name En
Middle name
Last name Amada

Organization

Cancer Institute Hospital of JFCR

Division name

Gastroenterology Center

Zip code

1358550

Address

3-8-31, Ariake, Koto-ku, Tokyo, Japan

TEL

+81-3-3520-0111

Homepage URL


Email

en.amada@jfcr.or.jp


Sponsor or person

Institute

JFCR

Institute

Department

Personal name



Funding Source

Organization

JFCR

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Cancer Institute Hospital of JFCR

Address

3-8-31, Ariake, Koto-ku, Tokyo, Japan

Tel

+81-3-3520-0111

Email

en.amada@jfcr.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2032 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 04 Month 28 Day

Last modified on

2019 Year 04 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041721


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name